Guillaume Baxter

Guillaume Baxter is a Partner at Sofinnova Partners, where since May 2017, investment efforts have focused on early-stage startups across Europe and North America in renewable-based chemistries, industrial biotechnologies, foodtech, and agbiotech. Additionally, Guillaume serves as a Board Member for companies including Qorium, Micropep Technologies, and Bon Vivant, and holds Board Observer roles for Protera Biosciences and Meiogenix. Previously, investment management responsibilities at Solvay included directing European investments and collaborating with Sofinnova Partners' industrial biotechnology team. Educational qualifications include a Master's degree in Biotechnology from Université de Technologie de Compiègne and additional degrees in Innovation Management and Immunology, among others.